Sirt1 protects from K-Ras-driven lung carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The NAD+-dependent deacetylase SIRT1 exhibits context-dependent roles in cancer, acting as either oncogenic or tumor suppressive.
• The function of SIRT1 in non-small cell lung carcinoma (NSCLC), a prevalent and lethal cancer often linked to K-RAS mutations, remains largely uncharacterized.

Purpose of the Study:

• To investigate the role of SIRT1 in K-RAS-driven lung carcinogenesis.
• To elucidate the impact of SIRT1 on the development and progression of non-small cell lung carcinoma.

Main Methods:

• Investigated SIRT1 protein levels in mouse embryo fibroblasts and human lung adenocarcinoma cell lines with oncogenic K-RAS.
• Utilized Sirt1 overexpression mouse models to assess the effect on K-RasG12V-driven lung adenocarcinoma development and survival.
• Analyzed molecular pathways altered by Sirt1 overexpression in isolated mouse pneumocytes following K-RasG12V activation.

Main Results:

• Oncogenic K-RAS downregulates SIRT1 protein levels in a MEK and PI3K-dependent manner.
• Sirt1 overexpression in mice significantly delays K-RasG12V-driven lung adenocarcinoma formation, reducing tumor burden and extending survival.
• Lower SIRT1 levels correlate with poorer prognosis in human NSCLC patients.

Conclusions:

• SIRT1 demonstrates a tumor suppressive function in the context of K-RAS-driven lung adenocarcinoma.
• The SIRT1-K-RAS axis represents a potential therapeutic target for non-small cell lung carcinoma.